NVCR vs. MELI

In the year-to-date period, NVCR achieves a 14.47% return, which is significantly lower than MELI's 25.24% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for NovoCure Limited (NVCR) and MercadoLibre, Inc. (MELI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NVCR Sharpe Ratio is 0.57, which is lower than the MELI Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of NVCR and MELI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither NVCR nor MELI has paid dividends to shareholders.

The maximum NVCR drawdown since its inception was -95.07%, which is greater than MELI's maximum drawdown of -89.49%. Use the drawdown chart below to compare losses from any high point for NVCR and MELI. For additional features, visit the drawdowns tool.

NovoCure Limited (NVCR) and MercadoLibre, Inc. (MELI) have volatilities of 20.13% and 20.32%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between NovoCure Limited and MercadoLibre, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.